Biogen Inc

NASDAQ: BIIB
$143.67
+$0.92 (+0.6%)
Closing Price on January 23, 2025

BIIB Articles

One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is the large cap biotechs.
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
The top analyst upgrades, downgrades and initiations seen on Tuesday, include Best Buy, Caterpillar, Nokia, UnitedHealth and Wal-Mart.
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off.
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
Thursday’s top analyst upgrades, downgrades and initiations include Biogen, Comerica, Deere, NVIDIA and Twenty-First Century Fox.
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
Tuesday’s top analyst upgrades, downgrades and initiations include Biogen, FedEx, Lionsgate Entertainment, Rexnord and RoadRunner Transportation.
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
Friday's top analyst upgrades, downgrades and initiations include Apple, Biogen, FedEx, General Electric and Las Vegas Sands.
The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
Friday’s top analyst upgrades, downgrades and initiations include Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines and Finisar.
The November 15 short interest data have been compared with the previous report, and short interest increased in most of the selected biotech stocks.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.